Form 4: GRAIL CFO Aaron Freidin Reports RSU Award, Tax-Related Stock Sales

GRAIL's Chief Financial Officer, Aaron Freidin, disclosed the acquisition of 60,118 restricted stock units and subsequent tax-related sales of 9,573 common shares.

Summary

• Aaron Freidin, Chief Financial Officer of GRAIL, Inc., reported transactions involving the company's common stock.
• On February 27, 2026, Freidin was awarded 60,118 restricted stock units (RSUs) at a price of $53.23 per unit.
• These RSUs will vest in four substantially equal annual installments, commencing on February 28, 2027, contingent on his continued service.
• On March 2, 2026, Freidin disposed of a total of 9,573 shares of common stock through two separate transactions.
• The sales included 9,135 shares at a weighted average price of $50.0853 and 438 shares at a weighted average price of $51.8611.
• These dispositions were automatic "sell-to-cover" transactions executed by a broker to satisfy withholding tax obligations related to award vesting and share delivery.
• Following these transactions, Freidin beneficially owns 309,622 shares of common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, primarily due to the significant RSU award to a key executive, which signals continued commitment and incentive alignment. The subsequent share sales are standard tax-related transactions and do not reflect a negative sentiment.

Positives

• The award of 60,118 restricted stock units (RSUs) to the Chief Financial Officer indicates continued incentive alignment with shareholder interests and retention of key management.
• The RSUs have a vesting schedule over four years, starting February 28, 2027, demonstrating a long-term commitment from the CFO.

Negatives

• The disposition of 9,573 shares, even if for tax purposes, represents a reduction in the CFO's direct common stock holdings.

Future Outlook

The restricted stock units awarded to the Chief Financial Officer are scheduled to vest in four substantially equal annual installments, beginning on February 28, 2027, contingent on his continued service to the company.

Industry Context

StockSavvy.ai notes that insider transaction disclosures like Form 4 are routine regulatory filings. The award of restricted stock units is a common practice in the biotechnology and healthcare industry to incentivize and retain key executives, aligning their interests with long-term company performance. Sell-to-cover transactions for tax purposes are also standard practice when equity awards vest.

Stakeholder Impact

• Shareholders: The RSU award aligns the CFO's long-term interests with shareholder value creation. The tax-related sales are a minor dilution event but are standard practice.
• Employees: The RSU award to a key executive may signal stability and continued investment in leadership.

Next Steps

• The awarded restricted stock units will begin vesting in four substantially equal annual installments starting February 28, 2027.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation and tax-related share dispositions. The RSU award is a positive for executive alignment, but the overall information does not provide new fundamental data to warrant a change in investment thesis. Investors should hold their position and monitor broader company performance and market trends.

Keywords

GRAIL Inc., GRAL, Aaron Freidin, Chief Financial Officer, CFO, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Award, Share Disposition, Sell-to-Cover, Executive Compensation